News Search

Elaine Larson is a professor of epidemiology at the Columbia Mailman School of Public Health and the School of Nursing.

“What it simply means is that the FDA will be able to accept applications and potentially permit them based on reasoning,” said Dietrich Egli, an assistant professor at Columbia University.

Dr. Kevin Kalinsky, an assistant professor of medicine at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, agreed that the new findings are important.